Publications by authors named "Celine Guinet"

Claim this Profile
L
Laboratory assessment of rivaroxaban: a review.
Meyer Michel Samama, Geneviève Contant, Theodore E Spiro, Elisabeth Perzborn, Lena Le Flem, Céline Guinet

Thromb J· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring plasma levels of factor Xa inhibitors: how, why and when?
Meyer-Michel Samama, Jean Amiral, Céline Guinet, Léna Le Flem, Jerard Seghatchian

Expert Rev Hematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of dabigatran and rivaroxaban in primary prevention of venous thromboembolism in 106 patients, who have undergone major orthopedic surgery: an observational study.
Meyer Michel Samama, Céline Guinet, Léna Le Flem, Emmanuel Ninin, Jean-Marc Debue

J Thromb Thrombolysis· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do new oral anticoagulants require laboratory monitoring? The clinician point of view.
Meyer Michel Samama, Céline Guinet, Lena Le Flem

Thromb Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trial.
Meyer Michel Samama, Genevieve Contant, Theodore E Spiro, Elisabeth Perzborn, Lena Le Flem, Céline Guinet

Clin Appl Thromb Hemost· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Meyer Michel Samama, Jeanne Mendell, Céline Guinet, Léna Le Flem, Satoshi Kunitada

Thromb Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.
Meyer Michel Samama, Genevieve Contant, Theodore E Spiro, Elisabeth Perzborn, Céline Guinet

Thromb Haemost· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory assessment of new anticoagulants.
Meyer M Samama, Céline Guinet

Clin Chem Lab Med· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.
Meyer Michel Samama, Jean Amiral, Céline Guinet, Elisabeth Perzborn, François Depasse

Thromb Haemost· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
Meyer Michel Samama, Jean-Luc Martinoli, Léna LeFlem, Céline Guinet, Geneviève Plu-Bureau

Thromb Haemost· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis